Orthocell Gains Approval for Collagen Scaffold Study

Orthocell was granted ethical approval by St Vincent’s Hospital Melbourne, Australia, for a clinical study using the Celgro SMRT Graft collagen scaffold.

Launching in 2Q16, the 25-patient study will investigate safety and tolerability of Celgro as a collagen matrix treatment for osteochondral defects in the hip—specifically, an enhanced...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0